No Surprises Act Arbitration Did Not Cost $22 Billion

A recent analysis published in Health Affairs claimed that the arbitration process established by the federal No Surprises Act (NSA) has contributed an estimated $22.4 billion in total costs. However, Radiology Partners, identified as the largest filer in this arbitration process, has contested this figure, asserting that the analysis contains significant errors and misinterpretations. The No Surprises Act, enacted in 2022, aims to protect patients from unexpected medical bills, particularly in emergency situations and for out-of-network care, by establishing a federal independent dispute resolution (IDR) process for payment disputes between providers and health plans. This IDR process allows for arbitration when providers and insurers cannot agree on a payment amount for out-of-network services. The Health Affairs analysis, authored by researchers from the University of Michigan and the University of Pennsylvania, reportedly used a methodology that extrapolated costs based on a limited dataset of arbitration decisions. Radiology Partners, a large physician practice management company, argues that the Health Affairs study incorrectly attributed the entire cost of arbitration, including the costs of services rendered, to the arbitration process itself. They contend that the $22.4 billion figure represents the total billed amounts for services subject to arbitration, not the additional costs incurred due to the arbitration process. Furthermore, Radiology Partners points out that the Health Affairs analysis failed to account for the fact that many arbitration decisions favored health plans, meaning the billed amounts were often reduced. The group also stated that the analysis did not consider the significant administrative costs borne by providers and insurers in participating in the arbitration process, which are separate from the billed service costs. Radiology Partners has indicated that a more accurate assessment of the arbitration process's financial impact would require a comprehensive review of all arbitration outcomes and associated administrative expenses, rather than a broad extrapolation from a subset of data. The group's critique suggests that the Health Affairs analysis may have overstated the financial burden of the NSA's arbitration mechanism, potentially misinforming policymakers and the public about the act's economic consequences. The No Surprises Act has been a subject of ongoing debate, with stakeholders on both sides of the provider-insurer divide scrutinizing its implementation and financial implications. Radiology Partners' rebuttal highlights the complexities involved in accurately measuring the cost of such regulatory mechanisms and underscores the importance of rigorous data analysis in evaluating their effectiveness and economic impact.